Kathryn M. Tully

An <i>in Vivo</i> Nanosensor Measures Compartmental Doxorubicin Exposure

Jackson D. Harvey, Ryan M. Williams, Kathryn M. Tully et al. · Nano Letters · 2019 · 63 citations

Engineering, Biomedical Engineering, Toxicology +17

A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals

Sai Kiran Sharma, Serge K. Lyashchenko, Hijin A. Park et al. · Nuclear Medicine and Biology · 2019 · 58 citations · Full text

Medicine, Nuclear Medicine, Pharmacology +10

Delta-like ligand 3–targeted radioimmunotherapy for neuroendocrine prostate cancer

Joshua A. Korsen, Julia Gutierrez, Kathryn M. Tully et al. · Proceedings of the National Academy of Sciences · 2022 · 57 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Bioorthogonal Masking of Circulating Antibody–TCO Groups Using Tetrazine-Functionalized Dextran Polymers

Jan‐Philip Meyer, Kathryn M. Tully, James Jackson et al. · Bioconjugate Chemistry · 2018 · 45 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +17

Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer

Patrícia M. R. Pereira, Komal Mandleywala, Sébastien Monette et al. · Nature Communications · 2022 · 41 citations · Full text

Medicine, Oncology, Pharmacology +17